Top in hem/onc: Blood thinners in women with miscarriage history; breast cancer risks - Healio

Recent information suggest that the usage of humor thinners whitethorn beryllium unnecessary successful women with a past of recurrent gestation nonaccomplishment and inherited thrombophilia, according to researchers.

The survey — presented astatine the American Society of Hematology’s Annual Meeting and Exposition — revealed a higher complaint of treatment-related adverse events among women who received antithrombotic therapy, starring researchers to counsel against regular usage successful women with recurrent miscarriages and inherited thrombophilia. It was the apical communicative successful hematology/oncology past week.

A model predicted the hazard for immune-related adverse events successful patients with early-stage, high-risk bosom cancer, according to researchers. Source: Adobe Stock

The 2nd apical communicative was astir a exemplary that predicted the hazard for immune-related adverse events successful patients with early-stage, high-risk bosom cancer. Researchers said the findings whitethorn assistance clinicians beryllium much diligent with monitoring during and aft treatment.

Read these and much apical stories successful hematology/oncology below:

Use of humor thinners whitethorn beryllium unnecessary successful women with recurrent gestation loss

The usage of low-molecular-weight heparin among large women with a past of recurrent miscarriage and inherited thrombophilia had nary effect connected the unrecorded commencement rate, results from the signifier 3 ALIFE2 proceedings showed. Read more.

Model predicts hazard for immune-related adverse events successful bosom crab subset

A grounds signifier exemplary predicted hazard for immune-related adverse events among women with early-stage, high-risk bosom cancer, according to an investigation of the signifier 2 I-SPY2 proceedings presented astatine San Antonio Breast Cancer Symposium. Read more.

BLOG: Navigating complexities of work-life balance

In this blog, Maryam Lustberg, MD, MPH, discusses the challenges of balancing enactment and family, and that “one-size prescriptive recommendations of ‘just accidental no’ oregon ‘family first’ don’t ever resonate.” Read more.

Study of CAR-T for patients with non-Hodgkin lymphoma, HIV yields 'reassuring' results

Chimeric antigen receptor T cells demonstrated acceptable efficacy with nary further information concerns erstwhile administered to patients with non-Hodgkin lymphoma and HIV, retrospective survey results showed. Read more.

VIDEO: Momelotinib benefits maintained astatine 24 weeks successful patients with anemic myelofibrosis

In this video, Aaron T. Gerds, MD, MS, an adjunct prof astatine the Cleveland Clinic Taussig Cancer Institute, discusses updated results from the Momentum signifier 3 survey presented astatine the ASH Annual Meeting and Exposition. Watch video.